HeyJaredThe MedTech Podcast
The MedTech Podcast shares the journey behind the path of the people shaping the MedTech industry and its future.
- Indexed episodes, last 90 days
- 5
- Latest publication
- Sep 29, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 20, 2026
Latest episodes
#107 Catching Disease Five Years Early with Caroline Vissers: Walking Away From Faculty, Why Investors Avoid Diagnostics and Rethinking When We Diagnose (opens the original)
Read excerpt
Caroline Vissers, co-founder of Immunectra and a former UCSF faculty member, who walked away from a lab of her own to build a company. Working alongside scientific co-founders Joe DeRisi and Michael Wilson, Caroline is developing blood-based tests capable of detecting autoimmune disease long before a patient ever shows symptoms. In this episode, Caroline shares why she gave up a faculty position most scientists spend a career chasing, how she prepared for the jump with a venture capital course a
#106 What Notified Bodies Actually Look For with Sandy Wright: Why SaMD Submissions Fail, the EU AI Act and Getting to Market Faster (opens the original)
Read excerpt
Sandy Wright, Head of Devices at Scarlet, the first notified body built specifically around software as a medical device. A former doctor who moved from clinical practice into digital health. Sandy now sits on the assessment side of the table, reviewing the very submissions most manufacturers dread putting together. In this episode, we start with the question that trips up so many companies. What actually turns a piece of software into a medical device and why is the wellness boundary still so b
#105 Inside the Transplant Industry with Tom Daulton: The Device Keeping Donated Organs Alive, Why the US Dominates Transplants and Building in a Niche Market (opens the original)
Read excerpt
Tom Daulton, CEO of Organ Recovery Systems, who has spent over 40 years in interventional medicine and building healthcare companies. Twelve months ago he knew very little about the transplant world. Today he runs one of the most fascinating businesses in it. In this episode, Tom explains what makes transplant unlike anything else in medicine, a field where sadly a patient has to die for another to live and where there is no pharmaceutical fallback the way dialysis can bridge a failing kidney. H
#104 From Investor to Inventor with Joanna Nathan: Rethinking Early Stage Lung Cancer Surgery, Raising Capital and the Changing Face of the Disease (opens the original)
Read excerpt
Joanna Nathan, CEO and co-founder of Prana Surgical, adjunct professor at Rice University and a former MedTech investor who spent years at the J&J MedTech Center for Device Innovation before crossing over into building herself. Her company recently secured FDA clearance for the Prana System, a tissue-sparing platform rethinking how early stage lung cancer is diagnosed and treated. In this episode, Joanna shares the deeply personal story behind her move from investing back into operating, having
#103 Why Faster Is Not Always Better with Basant Bajpai: EU MDR vs FDA, the GCC Regulatory Landscape and Where Innovators Get Stuck (opens the original)
Read excerpt
Dr. Basant Bajpai CEO of Compliance MedQRA, a UAE-based consulting company specializing in Quality Assurance, Regulatory Affairs, AI governance and compliance for medical devices, SaMD, AI/ML health technologies and digital health solutions. He holds a PhD in Neuroscience focused on brain monitoring and neurotechnology and has more than 12 years of international experience supporting MedTech and digital health companies across Europe, the Middle East and the United States. He explains why re
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Not enough subject data for this period yet.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.